In summary, we present the first spatial mapping of quantitative HP-tau, amyloid-β and α-synuclein TMA pathology in healthy ageing and a range of neurodegenerative dementias (AD, DLB, mixedAD/DLB, PDD). This evidence concerns the gene MAPT and Lewy body dementia.